What's in Gruppo Oncologico Italia Meridionale's pipeline?

Gruppo Oncologico Italia Meridionale has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Gruppo Oncologico Italia Meridionale's portfolio?

Top competitors by shared drug class: Dutch Colorectal Cancer Group, Lee's Pharmaceutical Limited.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/gruppo-oncologico-italia-meridionale.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Gruppo Oncologico Italia Meridionale — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Gruppo Oncologico Italia Meridionale pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
carboplatin paclitaxel bevacizumab	carboplatin paclitaxel bevacizumab	phase 3	Chemotherapy combination with anti-angiogenic monoclonal antibody	DNA (carboplatin), microtubules (paclitaxel), VEGF (bevacizumab)	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Dutch Colorectal Cancer Group · 1 shared drug class
Lee's Pharmaceutical Limited · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Gruppo Oncologico Italia Meridionale:

Cite this brief

Drug Landscape (2026). Gruppo Oncologico Italia Meridionale — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/gruppo-oncologico-italia-meridionale. Accessed 2026-05-17.